SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015858
Filing Date
2023-04-28
Accepted
2023-04-28 16:25:45
Documents
8
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A pyxs-14a_2023.htm DEF 14A 1231361
2 GRAPHIC img3736297_0.jpg GRAPHIC 29935
3 GRAPHIC img3736297_1.jpg GRAPHIC 17889
4 GRAPHIC img3736297_2.jpg GRAPHIC 41024
5 GRAPHIC img3736297_3.jpg GRAPHIC 29325
6 GRAPHIC img3736297_4.jpg GRAPHIC 17889
7 GRAPHIC img3736297_5.jpg GRAPHIC 102457
8 GRAPHIC img3736297_6.jpg GRAPHIC 60713
  Complete submission text file 0000950170-23-015858.txt   1629175
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40881 | Film No.: 23866885
SIC: 2834 Pharmaceutical Preparations